US FDA’s Breakthrough And RMAT Designations: A Quick Guide

Differences in eligibility and evidentiary criteria between the US FDA's two expedited regulatory programs are reflected in a new guide; metrics to date suggest comparable success rates for designation requests under the two programs. Our infographics aid in understanding the programs.

More from Review Pathways

More from Pathways & Standards